CAPTRUST Financial Advisors
JSPR icon

CAPTRUST Financial Advisors’s Jasper Therapeutics JSPR Stock Holding History

CAPTRUST Financial Advisors’s Portfolio JSPR Stock Details JSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-2,225
Closed -$221K – 4703
2021
Q2 		$221K Sell
2,225
-200
-8% -$19.9K ﹤0.01% 1441
2021
Q1 		$240K Sell
2,425
-162
-6% -$16.5K ﹤0.01% 1346
2020
Q4 		$259K Buy
2,587
+420
+19% +$41.8K ﹤0.01% 1091
2020
Q3 		$215K Sell
2,167
-15
-0.7% -$1.5K ﹤0.01% 998
2020
Q2 		$221K Buy
+2,182
New +$213K ﹤0.01% 990

Other funds holding JSPR

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPARFS
Leverage Partners Absolute Return Fund SPC Cayman Islands Ky1-11111, Cayman Islands $54K AUM
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CAPTRUST Financial Advisors's JSPR Position: Q3 2021 in Review

CAPTRUST Financial Advisors sold out of Jasper Therapeutics (JSPR) in Q3 2021, closing a stake of 2,225 shares — an estimated $221K sold.

CAPTRUST Financial Advisors first reported a position in JSPR in Q2 2020 and held it in 5 quarters. The position peaked at $259K in Q4 2020. 10 funds tracked by Wall St. Rank hold JSPR as of Q3 2021.

  • CAPTRUST Financial Advisors reported no remaining Jasper Therapeutics position as of Q3 2021 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 2,225 Jasper Therapeutics shares in Q3 2021, an estimated $221K.
  • CAPTRUST Financial Advisors first reported a position in Jasper Therapeutics in Q2 2020 and held it in 5 quarters.
  • CAPTRUST Financial Advisors's Jasper Therapeutics position peaked at $259K in Q4 2020.
  • 10 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2021.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.